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ABSTRACT
Featuring small sizes, caged structures, low cytotoxicity and the capability to
cross biological barriers, fullerene hydroxy derivatives named fullerenols have been
explored as nanomedicinal candidates for amyloid inhibition. Understanding the surface
chemistry effect of hydroxylation extents and the corresponding amyloid inhibition
mechanisms is necessary for enabling applications of fullerenols and also future designs
of nanomedicines in mitigating amyloid aggregation. Here, we investigated effects of
C60(OH)n with n = 0–40 on the aggregation of NACore (the amyloidogenic core region of
the non-amyloid-β component in α-synuclein), the amyloidogenic core of α-synuclein, by
computational simulations, transmission electron microscopy (TEM), Fourier transform
infrared (FTIR) spectroscopy, thioflavin-T (ThT) fluorescence kinetics and viability
assays. Computationally, NACore assembled into cross-β aggregates via intermediates
including β-barrels, which are postulated as toxic oligomers of amyloid aggregation.
Hydrophobic C60 preferred to self-assemble, and NACore bound to the surface of C60
nano-clusters formed β-sheet rich aggregates – i.e., having little inhibition effect.
Amphiphilic C60(OH)n with n = 4–20 displayed significant inhibition effects on NACore
aggregation, where hydrogen bonding between hydroxyls and peptide backbones
interrupted the formation of β-sheets between peptides adsorbed onto the surfaces of
fullerenols or fullerenol nano-assemblies due to hydrophobic interactions. Thus, both
cross-β aggregates and β-barrel intermediates were significantly suppressed. With
hydroxyls increased to 40, fullerenols became highly hydrophilic with reduced peptide
binding and thus an inhibition effect on amyloid aggregation. ThT, FTIR and TEM
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characterization of C60(OH)n with n = 0, 24, & 40 confirmed the computational
predictions. Our results and others underscore the importance of amphiphilic surface
chemistry and the capability of polar groups in forming hydrogen bonds with peptide
backbones to render amyloid inhibition, offering a new insight for de-novo design of antiamyloid inhibitors.
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CHAPTER ONE
INTRODUCTION
Amyloid aggregation of proteins or peptides (e.g., α-synuclein, Aβ, and amylin) is
associated with many pathological conditions, including Parkinson’s, Alzheimer’s
disease and type 2 diabetes.1–3 In all these diseases, amyloidogenic proteins or peptides
independent of their sequences and native structures aggregate into similar fibrillar
structures with a common cross-β core, where in-registered β-sheets formed between
peptides are aligned perpendicularly to the fibril axis.4–6 Amyloid cytotoxicity is mainly
attributed to the transient, soluble low molecular weight oligomers populated during the
aggregation process, although mature fibrils were also reported toxic.7 Experimental
evidence revealed that most cytotoxic aggregation species were β-sheet abundant.8
Inhibiting amyloid aggregation and especially the population of toxic β-sheet rich
intermediates is, therefore, an attractive therapeutic approach against amyloid diseases.
Many small molecular polyphenols, such as curcumin,9,10 resveratrol,9 and
EGCG,11,12 have been found to have anti-amyloid effects. The capacity of nanoparticles
crossing the blood–brain barrier13 opens new avenues to design anti-amyloid
nanomedicine beyond small molecule inhibitors. Various nanoparticles – such as gold
nanoparticles,14,15 fullerene,16,17 graphene,18 graphene oxide quantum dots,19,20
hydroxylated carbon nanotubes,21,22 silica nanohelices,23 polymeric dendrimers24 and star
polymers25 – have been explored for their effects on modulating amyloid aggregation and
mitigating cytotoxicity. Computational studies using molecular dynamics (MD)
simulations have also been used to investigate effects of various small molecules26,27 and

1

nanoparticles 23,28 on amyloid aggregation at the molecular and atomic levels. Due to
differential interactions of a given inhibitor with various aggregation species, including
monomeric peptides, oligomers and final fibrils,13 anti-amyloid effects can be achieved
by stabilizing monomers,24 promoting nontoxic off pathway oligomers,25 or reducing the
population of toxic oligomers with accelerated formation of none or less toxic fibrils.29
Mounting experimental studies established that nanoparticle properties such as the size
and surface chemistry play important roles in determining the mode and strength of their
interactions with proteins 30,31 and, thus, in modulating amyloid aggregation.14,32,33
Computational studies using simplified models 34,35 demonstrated that nanoparticles
could either promote or inhibit amyloid aggregation depending on binding affinities with
amyloid peptides. Since the peptide-binding affinity relies on the surface chemistry of
nanoparticles, uncovering the determinant of surface chemistry on amyloid aggregation
will be beneficial for the design of future anti amyloidosis nano inhibitors.
With features of small sizes, caged structures, low toxicities, and the capability to
cross biological barriers,36 fullerene nanoparticles and their derivatives have found
numerous biomedical applications,37 including the inhibition of amyloid
aggregation.16,28,38 Fullerenols, a class of fullerene derivatives functionalized with
hydroxyls (–OH) to increase their solubility and bioavailability,16,39 are particularly
attractive candidates for anti-amyloid inhibitors due to their resemblance of naturally
occurring anti-amyloid polyphenols.33 Indeed, several studies of fullerenols with a certain
number of hydroxyls have reported inhibition effects on amyloid aggregation of Aβ in
Alzheimer’s disease and amylin in type 2 diabetes.33,40 However, the effect of fullerenol
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surface chemistry with different extents of hydroxylation on amyloid aggregation remains
elusive. In this study, we systematically investigated the surface chemistry effect of
fullerenols with different numbers of hydroxyl groups on the aggregation of NACore, the
amyloidogenic core sequence fragment of α-synuclein (residues 68–78, also known as the
central hydrophobic core of the non-amyloid-β component) in Parkinson’s disease,4,41 by
using discrete molecular dynamics simulations (DMD) and complementary transmission
electron microscopy (TEM) and a thioflavin-T kinetics assay (ThT). Atomistic DMD
simulations – a rapid and accurate MD algorithm widely used to study protein dynamics,
protein folding and aggregation 42–47 – have already been used to uncover the effect of
fullerenol surface chemistry on the nanoparticle-binding induced impact of protein
structures and dynamics.30 We chose α-synuclein NACore as the model system since the
11-residue fragment is found necessary for the aggregation and cytotoxicity of full-length
α-synuclein;48 it has been experimentally shown to form amyloid fibrils with the
aggregates displaying high cytotoxicity,41,49 and importantly the fibril structure has
already been determined by X-ray crystallography.41
We computationally investigated the aggregation of NACore in the absence and
presence of fullerene or fullerenols C60(OH)n with n = 0, 4, 8, 12, 16, 20 & 40. Our DMD
simulations of NACore aggregation alone recapitulated the cross-β aggregation structure
as determined by X-ray crystallography.41 β-Barrel oligomers, recently populated as the
toxic oligomers of amyloid aggregation50 and found as common aggregation
intermediates,51,52 were also observed. In the mixture of fullerenes and NACore,
hydrophobic fullerenes self-assembled into nanoclusters while peptides adsorbed on the
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surfaces of fullerene clusters still formed β-sheet abundant aggregates, suggesting little
inhibition effect of insoluble fullerenes on amyloid aggregation in solution. Compared
with the purely hydrophobic C60, amphiphilic C60(OH)n with 4–20 hydroxyls
significantly inhibited the amyloid aggregation of NACore. The hydrogen bonds between
fullerenol hydroxyls and the backbone of the peptide bound to fullerenols or fullerenol
clusters interrupted the formation of inter-peptide β-sheets and rendered NACores in coil
conformations. Importantly, β-barrel oligomers, observed in the aggregation of pure
NACore or with C60, were also significantly reduced. As the number of polar hydroxyl
groups further increased, the aggregation inhibition effect of fullerenols started to
attenuate due to weaker peptide binding with decreasing hydrophobicity, and C60(OH)40
showed no inhibition effect in our simulations. Our complementary ThT and TEM
experiments of NACore aggregation in the presence of C60, C60(OH)24, and C60(OH)40
confirmed that highly hydrophobic C60 and highly hydrophilic C60(OH)40 had little
aggregation inhibition effects, but the amphiphilic C60(OH)24 could effectively inhibit
NACore from forming amyloid fibrils. Overall, our combined computational and
experimental studies underscore the amphiphilic surface chemistry and the ability of
polar groups to form hydrogen bonds with the peptide backbone to elicit anti-amyloid
properties, which may help design novel nanomedicines against amyloid diseases.
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CHAPTER TWO
RESULT AND DISCUSSION
To investigate the effect of fullerenol surface chemistry with different extents of
hydroxylation on the amyloid aggregation of NACore, we performed aggregation
simulations of peptides (×10) with or without the presence of fullerenes or fullerenols
(×5), including C60, C60(OH)4, C60(OH)8, C60(OH)12, C60(OH)16, C60(OH)20, and
C60(OH)40. For a given molecular system, twenty independent implicit solvent DMD
simulations each lasted 200 ns were performed at room temperature by starting from
different initial configurations of coordinates and velocities. The equilibration of each
system in simulations was assessed according to the time evolution of secondary structure
contents, which reached their steady states after 100 ns in all simulations (e.g.,
representative trajectories of each molecular system are shown in Fig. S1†). Hence, we
used the last 100 ns trajectories of each independent simulation for data analysis. To
validate our computational predictions, complementary TEM and ThT experiments were
performed for a set of representative nanoparticles, including hydrophobic C60,
amphiphilic C60(OH)24 and hydrophilic C60(OH)24.

Amphiphilic fullerenols significantly inhibited NACore β-sheet formation
To investigate the inhibition effects of fullerene and fullerenols on the amyloid
aggregation of NACore, we first examined the β-sheet propensity of the peptide in our
aggregation simulations. As mentioned above, we used the equilibrated last 100 ns
trajectories from all independent simulations for the secondary structure analysis. As
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shown in Fig. 1a, aggregation of NACore alone displayed a high β-sheet propensity, with
averaged coil and β-sheet propensities being ∼33% and 64%, respectively. The central
hydrophobic residues were mostly in β-sheet conformation (Fig. 1b). Peptides in the final
aggregates mainly adopted two-layer β-sheets with β-strands in different sheets aligned in
parallel (e.g., a representative structure in Fig. 1f), consistent with the experimentally
observed cross-β aggregate structure of NACore determined by X-ray crystallography.41
In the presence of fullerene C60, the β-sheet propensity slightly decreased with
overlapping error bars, indicating a weak inhibition effect of C60 on the formation of βsheet rich aggregates, consistent with previous studies of fullerenes interacting with other
amyloid peptides.28,38 Examination of final aggregates revealed that the fullerenes selfassembled into a single nano-cluster, while NACores adsorbed on the hydrophobic nanocluster surface still formed inter-peptide β-sheets (Fig. 1g). In contrast, with the
modification of adding only 4 hydroxyl groups, C60(OH)4 displayed a significant
inhibition effect for NACore in forming β-sheet rich structures (Fig. 1a and b). As the
number of hydroxyl groups increased, the inhibition effect decreased although C60(OH)20
still displayed significant inhibition effects compared to the control of pure NACore
aggregation. Similar to C60, these amphiphilic fullerenols with the number of hydroxyls
up to 20 also preferred to aggregate into a single nano-cluster, consistent with many
experimental reports of large self-assembled nano-clusters in fullerenol suspensions (Fig.
1h–l). Peptides attracted on the nano-cluster surfaces mainly adopted a random coil
conformation due to the disruption of hydrogen bonding between the nanoparticles and
the peptide backbone, while some small size β-sheets with two or three β-strands were
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also observed in the case of fullerenols with larger numbers of hydroxyl groups (Fig. 1e–
i). Interestingly, the highly hydroxylated C60(OH)40 was too hydrophilic to aggregate into
nano-clusters as in the cases of hydrophobic and amphiphilic nanoparticles (Fig. 1m), and
thus no aggregation inhibition was observed (Fig. 1a and b).
Based on equilibrated trajectories, we also computed the probability distribution
function (PDF) of the end-to-end distance of each peptide, and the distance between Cα
atoms of N- and C-terminal residues (Fig. 1c), as well as the total number of inter-peptide
hydrogen bonds (Fig. 1d) and between proteins and fullerenols (Fig. 1e). As expected, in
the control simulation of NACore aggregation, the eleven-residue peptide mostly adopted
a β-strand conformation with an extended end-to-end distance (e.g., a peak of ∼3.1 nm in
the PDF of Fig. 1c) and formed a large number of inter-peptide hydrogen bonds (e.g., a
peak of ∼80 hydrogen bonds in Fig. 1d). In the presence of C60 molecules, NACores still
adopted extended conformations with the peak of the end-toend distance PDF being ∼3.0
nm, and lost some inter-peptide hydrogen bonds due to structural mismatch between the
C60 nano-cluster and extend β-sheets (Fig. 1g). Amphiphilic fullerenols, on the other
hand, rendered NACore peptides less extended (Fig. 1c) as the peptides adsorbed on the
surface of fullerenol nano-clusters in bend and coil conformations (Fig. 1a and b), and
significantly reduced the number of interpeptide hydrogen bonds (Fig. 1d) due to the
competition of hydrogen bonding between peptides and the hydroxyl groups of the
nanoparticles (Fig. 1e). Interestingly, as the number of hydroxyl groups of C60(OH)n
increased until n ∼ 16, the total number of peptide–nanoparticle hydrogen bonds initially
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increased without affecting the number of inter-peptide hydrogen bonds (Fig. 1e), but
then started to decrease with the number of inter-peptide hydrogen increasing (i.e., the
inhibition effect weakens). With n = 40, the probability distributions of end-to-end
distances (Fig. 1c) and the total number of inter-chain hydrogen bonds (Fig. 1d) were
comparable to those of the control, and the formation of peptide-nanoparticle hydrogen
bonds became rare with the PDF peaked around zero (Fig. 1e).

Amphiphilic fullerenols inhibited the population of β-barrel oligomer intermediates
To understand the formation of β-sheet rich oligomers during NACore
aggregation, we computed the size distribution of β-sheets (i.e., the number of β-strands
forming the sheet), shown in Fig. 2a. In the control simulations, NACore predominantly
formed 5- and 10-strand β-sheets. The peak around 5-strand β-sheets corresponded to the
two-layer β-sheet structures (Fig. 1c and 2f, g). The large β-sheets with 8–10 strands in
our simulations (with ten peptides) were single β-sheets often in a close form as β-barrels
(Fig. 2e and f ). This type of β-barrel oligomer formed by amyloidogenic peptides, first
structurally determined from a slow-aggregating αB crystallin fragment, 50 has been
postulated as the potentially cytotoxic oligomer of amyloid aggregation due to its welldefined structures and compatibility to the “amyloid-pore” hypothesis of toxicity. 51,53,54
Possible formation of β-barrel oligomers was also reported in full length Aβ and
fragments.52,55–58 Recently, our systematic computational studies of multiple
amyloidogenic fragments using DMD simulations suggested that β-barrel oligomers were
common aggregation interiates towards the formation of cross-β like aggregates.51,59
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Fig.1 Inhibition of NACore β-sheet formation in silico. (a) The averaged content of
secondary structures including coils, β-sheets, β-bridges and bends from equilibrium
simulations. (b) The propensity of each amino acid to form coil and β-sheet
conformation. The probability distribution function (PDF) of (c) the end-to-end distance
(End2End), (d) the number of inter-chain hydrogen bonds (Hbond), and (e) the number of
hydrogen bonds formed with nanoparticles for each peptide. (f–m) Representative
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snapshot structures of each simulated molecular systems, randomly selected from 20
independent simulation trajectories.

The probability of observing β-barrel oligomers in equilibrated trajectories of
each molecular system was computed using a network-based algorithm of identifying βbarrel oligomers as closed β-sheets42 (Fig. 2b). In control simulations, NACore
displayed a high probability to form β-barrels during aggregation (∼20%, Fig. 2b). In the
presence of C60, we observed reduced population of β-barrel oligomers although the
probability of forming large size β-sheets with the number of β-strands of 7–10 was
increased (Fig. 2a and b). NACore oligomers adsorbed on the surfaces of fullerene nanoclusters formed either single β-sheets (Fig. 2g) or β-barrels (Fig. 2h). In contrast, NACore
peptides in the presence of amphiphilic fullerenols – e.g., C60(OH)n with n up to 20 –
only formed small β-sheets with 2–4 strands (Fig. 2a and i) while most peptides did not
form β-sheets (i.e., in coil conformations as shown in Fig. 1a and 2a). As a result, βbarrel oligomers were hardly detected in the presence of fullerenols with n = 4–12,
although the population of β-barrels increased with increasing hydroxylation levels (Fig.
2b). For instance, β-barrel formation was observed in the C60(OH)16 and C60(OH)20 (Fig.
2j) systems with a probability of ∼1.5% and ∼5.4%, respectively. As the number of
hydroxyl groups increased to 40, we observed similar size distributions of β-sheets and
population of β-barrels as in the control, suggesting little inhibition effect on NACore
aggregation and potential toxicity.
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Fig. 2 Conformational analysis of β-sheet containing aggregates. The probabilities of (a)
different sizes of β-sheets and (b) β-barrels observed in equilibrated simulations for each
system. (c–j) Representative β-sheet aggregations are shown, including (c–d) cross-β
aggregates and (e–f ) β-barrel intermediates in control simulations; (g) open and (h)
closed β-sheets formed by peptides in the presence of C60; (i) coil-rich aggregates of
NACore in the presence of amphiphilic C60(OH)8, and ( j) β-barrels in the presence of
more hydrophilic C60(OH)20.
Structural analyses of nanoparticle-peptide complexes revealed the inhibition
mechanism
To characterize inter–molecular interactions in the aggregates, we first calculated the
residue-wise inter–peptide contact probabilities between main-chain (MC) and side-chain
(SC) atoms (Fig. 3 & Fig. S2†). NACore, when aggregating alone, formed both parallel
and anti-parallel β-sheets with anti-parallel alignments being observed more frequently
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(e.g., the diagonal pattern in the main-chain contact frequencies of Fig. 3a and snapshots
in Fig. 1 and 2). The high contact frequency between hydrophobic residues indicated the
important role of hydrophobic interactions in NACore aggregation. Compared to control
simulations, amphiphilic fullerenols significantly reduced inter–peptide interactions
between both main-chains and side-chains while hydrophobic C60 and hydrophilic
C60(OH)40 displayed either weak or no inhibition effects on inter–peptide interactions,
fully consistent with the secondary structure analysis (Fig. 1a and b).
We further characterized the structural properties of molecular complexes formed
between peptides and nanoparticles during aggregation by computing the radial
distribution function (RDF) of the peptides or the nanoparticle atoms (Fig. 3b &
Fig. S2†). When NACores were aggregating in the presence of hydrophobic fullerene or
amphiphilic fullerenols, NACore formed stable molecular complexes with nanoparticles
located in the interior and peptides in the peripheral (Fig. 3b & Fig. S2†). With increasing
hydroxylation level, nanoparticles became less compact inside nanoparticle–peptide
complexes and proteins started to mix with the more hydrophilic fullerenols indicated by
the increased probability of finding protein atoms inside the fullerenol–peptide
complexes. In the case of C60(OH)40, the highly hydrophilic fullerenols were found
outside of peptide assemblies. We also estimated the probability distribution of the
peptide backbone or side-chain atoms as a function of their distances to nanoparticles or
nanoparticle assemblies (PDF in Fig. 3c), defined as the minimum distance between a
peptide atom and any nanoparticle atoms. In the presence of C60, there were two peaks
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for side-chain atoms, and one peak for main-chain atoms located between the two sidechain peaks. This corresponds to their molecular assemblies (e.g., Fig. 1g, 2g and h)
featuring peptides on the surface forming β-sheets with one side interacting with the
hydrophobic surface of C60 nano-clusters. Without polar groups forming hydrogen bonds
with peptide backbones, C60 preferred to interact with the side-chains instead of the
backbones of NACore. In contrast, amphiphilic fullerenols could form hydrogen bonds
with the peptide backbones and interact with the hydrophobic side-chains of NACore,
resulting in similar protein main-chain and side-chain PDFs on their nano-assembly
surface. As a result, amphiphilic fullerenols could effectively inhibit the formation of
inter-peptide hydrogen bonds and thus β-sheets, hindering amyloid aggregation.
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Fig. 3 Inter–peptide interactions and structural analyses of nanoparticle–peptide
complexes. (a) Per residue inter–peptide contact probabilities computed between mainchain (MC) and side-chain (SC) atoms for each molecular system. (b) Radial distribution
function (RDF) for both NACore and nanoparticle atoms in nanoparticle–peptide
complexes. (c) Probability distribution (PDF) of the peptide backbone or side-chain
atoms as the function of their distances to nanoparticles or nanoparticle assemblies,
defined as the minimum distance of a peptide atom to any nanoparticle atoms. Results for
C60(OH)8 and C60(OH)16 are shown in Fig. S2.†
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Biophysical experiments confirmed the predicted fibrillization inhibition of NACore
by amphiphilic C60(OH)24 and little effect by hydrophobic C60 and hydrophilic
C60(OH)40
To validate our computational predictions, ThT assay and TEM imaging were
applied to investigate the fibrillization kinetics and morphology of NACore in the
absence and presence of hydrophobic C60, amphiphilic C60(OH)24 and hydrophilic
C60(OH)40. Due to the limitation of commercial availability, C60(OH)24 was tested as the
representative amphiphilic fullerenol. Given the observed trends in our simulations (Fig.
1–3), we expected C60(OH)24 having a similar effect on NACore aggregation to that of
C60(OH)20.
ThT experiments showed that C60 had nearly no effects on NACore aggregation
kinetics over a wide-range of fullerene concentrations (4 μM, 0.2 mM, & 1 mM in Fig.
S3a†). C60(OH)24 could efficiently inhibit NACore fibrillization at sub-stoichiometry
concentrations of 2 and 4 μM by increasing the lag time and reducing the total amyloid
after saturation. As the fullerenol concentration increased to an equimolar ratio of 10 μM,
the amyloid aggregation was not detected within 36 h (Fig. S3b†). C60(OH)40 displayed
some weak inhibition effect only when its concentration increased to 20 μM or more (Fig.
S3c†). For comparison, the aggregations kinetics of NACore (10 μM) in the presence of
the same nanoparticle concentrations (4 μM) is shown in Fig. 4a. The aggregation
halftime of NACore at different concentrations of C60(OH)24 and C60(OH)40 is analyzed
in Fig. 4b, showing that C60(OH)24 could efficiently inhibit NACore fibrillization at substoichiometry concentrations while the concentration of C60(OH)24 had to be up to 100
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times in order to observe the aggregation inhibition effect. The secondary structure of
NACore w/o C60, C60(OH)24 and C60(OH)40 was further studied by using Fourier
transform infrared (FTIR) spectroscopy. The β-strand content for all samples displayed
increasing over 48 h of incubation (Fig. 5). However, the increase of β-strands was the
least in the presence of C60(OH)24 indicating reduced aggregation of NACore. This result
is consistent with our simulation data, where the β-sheet content of NACore in the
presence of C60(OH)20 (∼34.2%) was much lower than that in the presence of C60 or
C60(OH)40 (∼50.7% and ∼65.2%).
TEM imaging confirmed that C60 was hydrophobic with a high propensity to
agglomerate into micron-sized aggregates while C60(OH)24 and C60(OH)40 could be
suspended in solution without forming large aggregates (Fig. 6a–c). NACore alone
formed slender fibrils (Fig. 6d and h). In the presence of C60, NACores aggregated
around C60 clusters forming wide ribbonlike aggregates (Fig. 6e and i). Since the highly
hydrophobic fullerene molecules readily formed micron-sized aggregates having a
limited available surface area for interacting with peptides, C60 did not display the weak
aggregation inhibition effect as observed in silico, where a small number of C60 in
simulations formed only nano-sized clusters with a higher surface-bulk ratio and
relatively more active surface for peptide binding. The observation of NACores forming
fibrils around C60, likely due to fibril nucleation of peptides adsorbed onto the surface of
C60 aggregates, is consistent with the observation of NACore β-sheets formed around C60
nanoclusters in simulations (Fig. 1 and 2). As predicted by DMD simulations, C60(OH)24
strongly inhibited NACore from forming fibrils (Fig. 6f and j). In the presence of
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Fig. 4 NACore aggregation kinetics probed by the ThT assay. (a) Aggregation kinetics of
10 μM NACore in the absence and presence of 4 μM fullerene/fullerenol (black, NACore
only; red, C60(OH)24; blue, C60(OH)24; magenta, C60;). (b) Half-time (t1/2) of NACore
aggregation as a function of the fullerenol concentration (red, C60(OH)24; blue,
C60(OH)24) derived from sigmoidal fitting. Error bars represent standard deviations of
three independent measurements.
C60(OH)40, NACore formed shorter and slightly wider aggregates compared to the
control. The experimentally observed aggregation morphology change and the retardation
of aggregation at high C60(OH)40 concentrations (Fig. 4b & S3†) might result from the
dynamic and weak hydrogen bonding between C60(OH)40 and peptides as revealed in
simulations (Fig. 1e). Especially at high concentrations, C60(OH)40 effectively slowed
down the aggregation kinetics and also allowed the accumulation of more aggregation
nuclei.
Both the computational and experimental data revealed that C60(OH)24 could
effectively inhibit the amyloid fibrillization of NACore. To evaluate whether the
inhibition of aggregation could also reduce the cytotoxicity of NACore, the viability of
SH-SY5Y neuronal cells exposed to NACore with or without C60(OH)24 was analysed
(Fig. S4†). The cell death probability result showed that C60(OH)24 had low cytotoxicity
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itself and could effectively reduce the toxicity of NACore. Since the aggregation
inhibition effects of fullerene and its hydroxyl derivatives were studied on NACore, we
also tested their effects on the aggregation of full length α-synuclein by the ThT assay
(Fig. S5†). Similarly, C60(OH)24 was the most effective inhibitor of the protein
aggregation, whereas C60(OH)40 was less effective and C60 did not show any effect on the
rate of aggregation (Fig. S4†). The amyloid aggregation of full length α-synuclein,
especially the formation of soluble oligomers, could cause lipid membrane leakage and
cell death.60–62 Our results also validated the use of NACore as a model system for
understanding the aggregation behavior of full length α-synuclein.

Importance of amphiphilic surface chemistry in eliciting inhibition effects on
amyloid aggregation
Our computational and experimental results revealed that amphiphilic fullerenols
C60(OH)n with a wide-range of hydroxylation levels (e.g., n = 4–24) had significant
inhibition effects on amyloid aggregation of NACore, while hydrophobic fullerene or
highly hydrophilic fullerenol C60(OH)40 had no or weak effects. Many nanoparticle
inhibitors reported in the literature also feature amphiphilic surface chemistry. For
example, amphiphilic graphene oxides and nanocomposites containing graphene oxides
were found to inhibit the amyloid aggregation of Aβ,63,64 amylin,19 and α-synuclein.20
Complementary to experimental studies, the inhibition mechanisms of these carbon-based
amphiphilic nanoparticles were also well studied computationally.21,22,28,65,66 In addition,
the OH-terminated PAMAM dendrimer, an amphiphilic macromolecule, could inhibit
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Fig. 5 (a) Characterization of NACore secondary structure upon interaction with C60,
C60(OH)24 and C60(OH)40 over time. (b) FTIR spectra indicate decrease in random coils
(peak 1640–1648 cm−1) and increase of β strands (peak 1624–1640 cm−1) over 48 h of
the incubation.
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Fig. 6 NACore aggregation morphology probed by TEM imaging. TEM images of (a)
hydrophobic C60, (b) amphiphilic C60(OH)24 and (c) hydrophilic C60(OH)40. NAcore
aggregates in the absence (d and h) and presence of (e and i) C60, (f and g) C60(OH)24, and
(g and k) C60(OH)40.
amylin aggregation.24 Anti-amyloid small molecule polyphenols,9 such as curcumin,9,10
resveratrol9 and EGCG,11,12 are also amphiphilic in nature. Overall, these studies support
the notion that the amphiphilic surface chemistry is likely necessary for eliciting
inhibition effects on amyloid aggregation. Proteins and peptides are intrinsically
amphiphilic polymers, the hydrophobic component of amphiphilic inhibitor surface
chemistry drives the binding between inhibitors and amyloidogenic peptides and the
ability of surface polar groups (such as hydroxyls) forming hydrogen bonds with peptide
backbones competes with the formation of inter–peptide hydrogen bonds, thus inhibiting
the formation of inter–peptide β-sheets and, subsequently, fibrillization.
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Figure S1. Time evolution of primary secondary structure contents in term of random
coil (black) and β-sheet (red) of NACore peptides in each molecular system, suggesting
the equilibration of DMD simulations in the last 100 ns. For each system, one randomly
selected trajectory out of twenty independent DMD simulations was shown.

Figure S2. Inter-peptide interactions and structural analyses of nanoparticle-peptide
complexes. (a) Per residue inter-peptide contact probabilities computed between mainchain (MC) and side-chain (SC) atoms for each molecular system. (b) Radial distribution
function (RDF) for both NACore and nanoparticle atoms in nanoparticle-peptide
complexes. (c) Probability distribution (PDF) of peptide backbone or side-chain atoms as
a function of their distances to nanoparticles or nanoparticle assemblies, defined as the
minimum distance of a peptide atom to any nanoparticle atoms.
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Figure S3. ThT fluorescence intensity of NACore aggregation (10 μM) as a function of
time in the absence and presence of fullerene/fullerenol nanoparticles at different
concentrations.

Figure S4. Viability of SH-SY5Y neuronal cells exposed to NACore with or without
C60(OH)24 of 5, 15 and 25 μM. Exposure time: 24 h. Consistent with the simulation result,
C60(OH)24 was effective in reducing the NACore toxicity, indicating a strong binding
affinity with NACore. PI: propidium iodide. The experiments were carried out in
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triplicate and error bars show standard deviations (****: P ≤ 0.0001). NACore
concentration: 100 μM.

Figure S5. α-synuclein aggregation kinetics probed by the ThT assay. (a) Aggregation
kinetics of 50 μM α-synuclein in the absence and presence of 50 μM fullerene/fullerenol
(black, α synuclein only; magenta, C60; red, C60(OH)24; blue, C60(OH)24). (b) Half‐time
(t1/2) of α-synuclein aggregation derived from sigmoidal fitting. Error bars represent
standard deviations of three independent measurements (ns : P> 0.05, *: P ≤ 0.05, **: P ≤
0.01).
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CHAPTER THREE
CONCLUSIONS
We systematically studied the effects of fullerene and its hydroxyl derivatives,
C60(OH)n with n = 0–40, on the amyloid aggregation of NACore peptides using atomistic
DMD simulations and commentary experimental characterization with TEM, FTIR,
viability and ThT. Our computational simulations of NACore aggregation alone
recapitulated the formation of cross-β structures as observed in prior X-ray
crystallography studies.41 β-Barrel oligomers, recently postulated as potentially toxic
oligomers,50,51,55,56,58 were also detected as the aggregation intermediates. The
hydrophobic fullerenes preferred to self-assemble into nano-clusters and peptides bound
to the nano-cluster surface still formed β-sheet rich aggregates as β-barrel oligomers.
Amphiphilic fullerenols with up to ∼20 hydroxyl groups displayed significant inhibition
effects on NACore aggregation. Amphiphilic fullerenols also formed nano-clusters, but
surface hydroxyl groups formed hydrogen bonds with the backbone of peptides bound to
the surface, efficiently reducing the formation of inter–peptide hydrogen bonds and thus
β-sheets. As a result, the formation of both cross-β and β-barrel structures was strongly
inhibited. As the number of hydroxyl groups increased up to 40, the hydrophilic
C60(OH)40 only had weak interactions with the peptides and showed little aggregation
inhibition. ThT, FTIR and TEM experiments with C60, C60(OH)24 and C60(OH)40,
representing hydrophobic, amphiphilic and hydrophilic nanoparticles, respectively,
confirmed our predictions. Our results, together with prior reports of anti-amyloid
nanoparticles21,22,24,28,65,66 and small molecules9–12 in the literature, underscore the
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amphiphilic surface chemistry and the ability of polar groups to form hydrogen bonds
with the peptide backbone to elicit anti-amyloid properties, which may help the design of
novel theranostics against amyloid diseases.

25

CHAPTER FOUR
MATERIALS AND METHODS
Simulation system setup
Our model peptide in this study is a central segment of α-synuclein, residues
68

GAVVTGVTAVA78 due to its critical role in both the aggregation and cytotoxicity of

α-synuclein. In order to investigate the effects of fullerene and its derivatives on NACore
amyloid aggregation, eight different systems were well studied, where 10 NACore
peptides with/without five fullerene/fullerenol (i.e., C60, C60(OH)4, C60(OH)8, C60(OH)12,
C60(OH)16, C60(OH)20, C60(OH)40) were simulated. Both the NACore peptides and
fullerene/fullerenol molecules were randomly placed in a 7.0 nm cubic simulation box
with the minimum distance between inter-chain molecules of no less
than 1.5 nm. The initial conformation of the NACore segments was set as fully extended.
For each molecular system, 20 independent DMD simulations were performed for 200 ns,
with an accumulated simulation time of 4 μs, starting with different initial configurations
(i.e., orientations, coordinates and velocities).

DMD simulations
All simulations were performed using the discrete molecular dynamics (DMD)
algorithm.67 DMD is a unique type of molecular dynamics algorithm, where the inter–
atom interaction potentials are modeled by step functions.44 Details of DMD simulations
were discussed in our prior studies.68 With significantly enhanced sampling efficiency,
DMD was widely used to study protein folding/aggregation,43,69 and protein-nanoparticle
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interactions.23 The units of mass, time, length, and energy used in our all-atom with an
implicit water model were 1 Da, ∼50 femtosecond, 1 Å, and 1 kcal mol−1, respectively.
The temperature of the system was maintained at 300 K using the Anderson’s thermostat.
In all cases, the peptide concentration was kept around 48 mM.

Computational analysis
The secondary structure was calculated using the DSSP program.70 Similar to
prior simulation studies, a hydrogen bond was considered to be formed if the distance
between the backbone N and O atoms was ≤3.5 Å and the angle of NH⋯O ≥ 120°.71
Inter–chain peptide interactions were analyzed by the residue–residue contact frequency.
Here, a pairwise residue contact was defined when the distance between the heavy atoms
of two non-sequential residues was <0.65 nm. Two chains were considered to form a βsheet if (i) at least two consecutive residues in each chain adopted the β-strand
conformation and (ii) formed at least two backbone hydrogen bonds. If each peptide was
connected by two β-sheet neighbors and formed a closed cycle oligomer, this oligomer
was treated as a β-barrel structure.42 The radial distribution function g(r) of atom in each
system corresponding to the complex center was calculated by the following equation
g(r) = Nr,r+dr/(4πr2dr), where Nr,r+dr is the number of atoms within distances of r and r
+ dr away from the center of the complex.
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Experimental preparation of NACore and fullerene/fullerenol
The NACore peptide, with sequence GAVVTGVTAVA, was synthesized and
HPLC purified by GenScript. Full-length α-synuclein was purchased from AlexoTech
(purity 95% HPLC). The fullerene C60 (cat no. MT-60-2) and fullerenol C60(OH)24(ONa)4
(cat no. FI-06-02) were purchased from Materials Technologies Research Ltd. The
fullerenol C60(OH)40 (cat no. 793248) was purchased from Sigma-Aldrich Co. LLC. The
lyophilized powder of the NACore peptide was first solubilized in 100%
hexafluorosiopropanol (HFIP) (Sigma) at ∼1 mM and sonicated at 30% power efficiency
for 30 s (Qsonica Q125) to break preformed aggregation. The concentration was then
determined spectrophotometrically using a calculated extinction coefficient at 280 nm.
Lyophilized α-synuclein was reconstituted in Milli-Q water.

Thioflavin-T fluorescence assay
The kinetics of NACore and α-synuclein aggregation were monitored by using the
dye Thioflavin T (ThT), the fluorescence of which was dependent on the formation of
amyloid fibrils. To initiate fiber formation, the NACore peptide stock was diluted to a
final concentration of 10 μM in 100 mM HEPEs (pH 7.4), and 20 μM ThT (Sigma), and
varying concentrations of fullerene/fullerenol. All buffers were passed through a HiTrap
Chelating HP Column (GE Healthcare) to remove trace amounts of endogenous divalent
cations. For α-synuclein kinetics assay the protein was diluted to a final concentration
of 50 μM, and ThT concentration in the assay was 50 μM. The assays were performed in
a sealed Corning 96-well flat bottom, nonbinding surface plates (black), and measured by
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exciting the ThT in samples at 440 nm and reading the emission at 485 nm at a constant
temperature of 37 °C using a BioTek Synergy H1 Hybrid Reader with continuous
shaking at 425 cpm between measurements.

Transmission electron microscopy
All samples were sonicated at 30% power efficiency for 30 s to break preformed
aggregation before mixing. Each sample contained 20 μg mL−1 NACore peptide and
with/without 20 μg mL−1 fullerene/fullerenol, respectively, was incubated at 37 °C
for 24 h and absorbed onto 200-mesh formvar/carbon-coated copper grids. TEM images
were acquired using a Hitachi H-7600 transmission electron microscope at 100 kV.

Fourier transform infrared (FTIR) spectroscopy
The FTIR spectra of NACore were obtained using a Shimadzu IRTracer-100
spectrophotometer. For this, 5 μL of 100 μM NACore w/o C60, C60(OH)24 and C60(OH)40
(100 μM) from 0 to 48 h of incubation time were placed on a sample holder and air dried,
and their spectra were acquired between 600 and 4000 cm−1 at 20 °C with a resolution of
4 cm−1. A blank spectrum was acquired and subtracted from the sample spectra. Peak
fitting and secondary structure analysis were performed using PeakFit v4.12 (SeaSolve
Software Inc.).
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Cell culture and viability assay
SH-SY5Y neuronal cells were cultured in Dulbecco’s Modified Eagle’s Medium:
Nutrient Mixture F-12 (DMED-F12, purchased from ATCC) with 10% fetal bovine
serum (FBS). A black clear bottom Costar well plate was coated with poly-L-lysine for
30 min at 37 °C and 5% CO2 to enhance cell adhesion. After washing the wells with PBS,
∼50 000 cells were added to each well. The cells were incubated at 37 °C and 5% CO2 to
reach ∼80% confluence. The DMED-F12 was then refreshed with 1 μM PI dye in
DMEM: F12 and incubated for 30 min. The cells were treated with 100 μM of NACore
w/o C60(OH)24 (in three different concentrations of 5, 15 and 25 μM). Untreated
cells were recorded as controls. All samples were examined in triplicate. The results were
measured by using an Operetta (PerkinElmer, 20× PlanApo microscope objective,
numerical aperture NA = 0.7) in a live cell chamber (37 °C, 5% CO2) after 24 h of
treatment. The percentage of dead cells (PI-positive) relative to the total cell count was
determined by a built-in bright-field mapping function of Harmony High-Content
Imaging and Analysis software (PerkinElmer).
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